A Clinical Practice Guideline from the US Public Health Service suggests that when feasible and not medically contraindicated, tobacco cessation interventions should include at least one Food and Drug Administration (FDA)-approved pharmaceutical aid in combination with tobacco dependence counseling.  Here we summarize the medications currently available in the United States for smoking cessation. Approaches for behavioral interventions are presented elsewhere and will not be addressed.